2022 Q1 Form 10-Q Financial Statement

#000100075322000022 Filed on April 26, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q3 2021 Q1
Revenue $1.578B $1.210B $1.287B
YoY Change 22.61% 20.02% 4.66%
Cost Of Revenue $1.292B $1.011B $1.035B
YoY Change 24.79% 22.89% 4.01%
Gross Profit $285.8M $198.5M $251.4M
YoY Change 13.65% 7.27% 7.45%
Gross Profit Margin 18.11% 16.41% 19.54%
Selling, General & Admin $177.2M $149.0M $159.6M
YoY Change 11.02% 0.38% 13.03%
% of Gross Profit 62.01% 75.05% 63.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.18M $9.917M $8.000M
YoY Change 27.3% 27.14% 5.26%
% of Gross Profit 3.56% 5.0% 3.18%
Operating Expenses $187.4M $158.9M $167.6M
YoY Change 11.79% 1.67% 12.65%
Operating Profit $98.40M $39.60M $83.82M
YoY Change 17.38% 37.64% -1.64%
Interest Expense $1.925M $1.963M $1.599M
YoY Change 20.39% 13.4% -32.3%
% of Operating Profit 1.96% 4.96% 1.91%
Other Income/Expense, Net
YoY Change
Pretax Income $96.62M $37.89M $82.77M
YoY Change 16.73% 39.59% -2.32%
Income Tax $26.73M $10.60M $20.85M
% Of Pretax Income 27.67% 27.96% 25.19%
Net Earnings $69.88M $27.30M $61.92M
YoY Change 12.86% 36.42% -0.27%
Net Earnings / Revenue 4.43% 2.26% 4.81%
Basic Earnings Per Share $1.82 $0.71 $1.62
Diluted Earnings Per Share $1.80 $0.70 $1.59
COMMON SHARES
Basic Shares Outstanding 38.29M shares 38.52M shares 38.22M shares
Diluted Shares Outstanding 38.69M shares 38.88M shares 38.84M shares

Balance Sheet

Concept 2022 Q1 2021 Q3 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $609.3M $500.6M $529.1M
YoY Change 15.15% 23.18% 24.73%
Cash & Equivalents $576.7M $467.9M $494.8M
Short-Term Investments $32.61M $32.70M $34.30M
Other Short-Term Assets $80.28M $53.29M $53.72M
YoY Change 49.45% 57.8% 32.88%
Inventory
Prepaid Expenses
Receivables $670.2M $579.5M $561.2M
Other Receivables $0.00 $5.584M $3.500M
Total Short-Term Assets $1.432B $1.206B $1.252B
YoY Change 14.42% 15.03% 15.96%
LONG-TERM ASSETS
Property, Plant & Equipment $205.1M $212.3M $220.3M
YoY Change -6.9% 8.21% 37.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $21.11M $12.09M $6.955M
YoY Change 203.48% 92.23% 15.72%
Total Long-Term Assets $508.2M $527.6M $517.6M
YoY Change -1.82% 11.21% 16.8%
TOTAL ASSETS
Total Short-Term Assets $1.432B $1.206B $1.252B
Total Long-Term Assets $508.2M $527.6M $517.6M
Total Assets $1.940B $1.734B $1.769B
YoY Change 9.67% 13.84% 16.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.826M $4.250M $5.841M
YoY Change 33.98% -29.36% -6.39%
Accrued Expenses $86.63M $70.82M $61.11M
YoY Change 41.77% 52.64% 18.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.287B $1.004B $1.044B
YoY Change 23.2% 19.39% 17.55%
LONG-TERM LIABILITIES
Long-Term Debt $369.4M $369.4M $369.4M
YoY Change 0.0% 0.0% 0.0%
Other Long-Term Liabilities $245.0M $263.5M $268.3M
YoY Change -8.68% -2.2% 3.47%
Total Long-Term Liabilities $619.5M $632.9M $651.1M
YoY Change -4.85% -1.36% 2.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.287B $1.004B $1.044B
Total Long-Term Liabilities $619.5M $632.9M $651.1M
Total Liabilities $1.906B $1.637B $1.695B
YoY Change 12.43% 10.41% 11.12%
SHAREHOLDERS EQUITY
Retained Earnings $605.0M $637.9M $620.2M
YoY Change -2.45% 8.83% 13.73%
Common Stock $110.6M $105.1M $81.88M
YoY Change 35.08% 39.9% 74.66%
Preferred Stock
YoY Change
Treasury Stock (at cost) $681.6M $646.0M $628.4M
YoY Change 8.47% 4.09% 5.53%
Treasury Stock Shares
Shareholders Equity $33.96M $97.01M $73.64M
YoY Change
Total Liabilities & Shareholders Equity $1.940B $1.734B $1.769B
YoY Change 9.67% 13.84% 16.2%

Cashflow Statement

Concept 2022 Q1 2021 Q3 2021 Q1
OPERATING ACTIVITIES
Net Income $69.88M $27.30M $61.92M
YoY Change 12.86% 36.42% -0.27%
Depreciation, Depletion And Amortization $10.18M $9.917M $8.000M
YoY Change 27.3% 27.14% 5.26%
Cash From Operating Activities $58.85M $47.85M $1.971M
YoY Change 2885.64% -676.48% -91.71%
INVESTING ACTIVITIES
Capital Expenditures $4.686M -$2.895M $12.07M
YoY Change -61.18% -90.12% -22.74%
Acquisitions
YoY Change
Other Investing Activities -$1.204M $1.709M $0.00
YoY Change -171.21% -100.0%
Cash From Investing Activities -$5.890M -$1.186M -$12.08M
YoY Change -51.23% -96.25% 3746.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$43.89M -27.82M -$42.40M
YoY Change 3.51% -35.75% -265.59%
NET CHANGE
Cash From Operating Activities $58.85M 47.85M $1.971M
Cash From Investing Activities -$5.890M -1.186M -$12.08M
Cash From Financing Activities -$43.89M -27.82M -$42.40M
Net Change In Cash $9.071M 18.84M -$52.50M
YoY Change -117.28% -122.65% -206.98%
FREE CASH FLOW
Cash From Operating Activities $58.85M $47.85M $1.971M
Capital Expenditures $4.686M -$2.895M $12.07M
Free Cash Flow $54.16M $50.74M -$10.10M
YoY Change -636.19% 141.63% -223.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
INSPERITY, INC.
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001000753
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38307974 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1774000 USD
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
27441000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
0 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9846000 USD
CY2022Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-782000 USD
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
17244000 USD
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-92000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
69884000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
33961000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
61922000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
44132000 USD
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
29686000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11822000 USD
CY2021Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-682000 USD
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15461000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-7000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
73644000 USD
CY2022Q1 nsp Time Period Incurred Claims Expected To Be Paid Included In Deposits
TimePeriodIncurredClaimsExpectedToBePaidIncludedInDeposits
Greater than 1 year
CY2022Q1 nsp Time Period Estimate Of Incurred Claim Costs To Be Paid Included In Long Term Liabilities
TimePeriodEstimateOfIncurredClaimCostsToBePaidIncludedInLongTermLiabilities
Greater than 1 year
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
1-13998
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
76-0479645
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
19001 Crescent Springs Drive
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Kingwood,
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77339
CY2022Q1 dei City Area Code
CityAreaCode
281
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
358-8986
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38307974 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
576654000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
575812000 USD
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
49429000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
46929000 USD
CY2022Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
32610000 USD
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
31791000 USD
CY2022Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
670223000 USD
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
513306000 USD
CY2022Q1 us-gaap Prepaid Insurance
PrepaidInsurance
22716000 USD
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
11285000 USD
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
80282000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
53312000 USD
CY2022Q1 us-gaap Nontrade Receivables
NontradeReceivables
0 USD
CY2021Q4 us-gaap Nontrade Receivables
NontradeReceivables
12413000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
1431914000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1244848000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
205064000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
210723000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61629000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
62830000 USD
CY2022Q1 nsp Prepaid Health Insurance Noncurrent
PrepaidHealthInsuranceNoncurrent
9000000 USD
CY2021Q4 nsp Prepaid Health Insurance Noncurrent
PrepaidHealthInsuranceNoncurrent
9000000 USD
CY2022Q1 nsp Deposits Health Insurance
DepositsHealthInsurance
7900000 USD
CY2021Q4 nsp Deposits Health Insurance
DepositsHealthInsurance
7900000 USD
CY2022Q1 nsp Deposits Workers Compensation
DepositsWorkersCompensation
190756000 USD
CY2021Q4 nsp Deposits Workers Compensation
DepositsWorkersCompensation
185027000 USD
CY2022Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
12707000 USD
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
12707000 USD
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4892000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21107000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15158000 USD
CY2022Q1 us-gaap Assets
Assets
1940077000 USD
CY2021Q4 us-gaap Assets
Assets
1753085000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7826000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6412000 USD
CY2022Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
384767000 USD
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
467892000 USD
CY2022Q1 nsp Accrued Worksite Employee Payroll Costs
AccruedWorksiteEmployeePayrollCosts
645623000 USD
CY2021Q4 nsp Accrued Worksite Employee Payroll Costs
AccruedWorksiteEmployeePayrollCosts
409653000 USD
CY2022Q1 nsp Accrued Health Insurance Costs
AccruedHealthInsuranceCosts
61399000 USD
CY2021Q4 nsp Accrued Health Insurance Costs
AccruedHealthInsuranceCosts
50001000 USD
CY2022Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
53290000 USD
CY2021Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
50534000 USD
CY2022Q1 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
43279000 USD
CY2021Q4 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
74778000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
86627000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
69303000 USD
CY2022Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
3784000 USD
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
0 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1286595000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1128573000 USD
CY2022Q1 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
182888000 USD
CY2021Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
192694000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
369400000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
369400000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
62119000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
64192000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5114000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 USD
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
619521000 USD
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
626286000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
555000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
555000 USD
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
110053000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
109179000 USD
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
681625000 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
665089000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
604978000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
553581000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
33961000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1774000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1940077000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1753085000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1577837000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1286835000 USD
CY2022Q1 nsp Payroll Taxes Benefits And Workers Compensation Costs
PayrollTaxesBenefitsAndWorkersCompensationCosts
1292063000 USD
CY2021Q1 nsp Payroll Taxes Benefits And Workers Compensation Costs
PayrollTaxesBenefitsAndWorkersCompensationCosts
1035390000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
285774000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
251445000 USD
CY2022Q1 nsp Salaries Wages And Payroll Taxes
SalariesWagesAndPayrollTaxes
107439000 USD
CY2021Q1 nsp Salaries Wages And Payroll Taxes
SalariesWagesAndPayrollTaxes
103075000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9846000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11822000 USD
CY2022Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
10310000 USD
CY2021Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
7719000 USD
CY2022Q1 us-gaap Advertising Expense
AdvertisingExpense
8595000 USD
CY2021Q1 us-gaap Advertising Expense
AdvertisingExpense
5322000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41005000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31636000 USD
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10184000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8047000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
187379000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
167621000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
98395000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
83824000 USD
CY2022Q1 us-gaap Interest Income Other
InterestIncomeOther
148000 USD
CY2021Q1 us-gaap Interest Income Other
InterestIncomeOther
543000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
1925000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
1599000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
96618000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
82768000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26734000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20846000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
69884000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
61922000 USD
CY2022Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
47000 USD
CY2021Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
197000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
69837000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
61725000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.82
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.62
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.80
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.59
CY2022Q1 nsp Gross Billings
GrossBillings
10357905000 USD
CY2021Q1 nsp Gross Billings
GrossBillings
8050422000 USD
CY2022Q1 nsp Worksite Employee Payroll Cost
WorksiteEmployeePayrollCost
8780068000 USD
CY2021Q1 nsp Worksite Employee Payroll Cost
WorksiteEmployeePayrollCost
6763587000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1577837000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1286835000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
69884000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
61922000 USD
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10184000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8047000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9846000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11822000 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
10006000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
22946000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
156917000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
168498000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
11431000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
47506000 USD
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
26970000 USD
CY2021Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
14257000 USD
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1588000 USD
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1508000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1414000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-362000 USD
CY2022Q1 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-83125000 USD
CY2021Q1 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-67441000 USD
CY2022Q1 nsp Increase Decreasein Wse Epayrollexpense
IncreaseDecreaseinWSEEpayrollexpense
235970000 USD
CY2021Q1 nsp Increase Decreasein Wse Epayrollexpense
IncreaseDecreaseinWSEEpayrollexpense
168498000 USD
CY2022Q1 us-gaap Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
11398000 USD
CY2021Q1 us-gaap Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
39451000 USD
CY2022Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-7050000 USD
CY2021Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-3393000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-18971000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-5421000 USD
CY2022Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
16197000 USD
CY2021Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-5345000 USD
CY2022Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-11037000 USD
CY2021Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-59951000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
58847000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1971000 USD
CY2022Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
6964000 USD
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
10585000 USD
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
5760000 USD
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
10580000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4686000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12072000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5890000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12077000 USD
CY2022Q1 nsp Treasury Stock Acquired
TreasuryStockAcquired
27441000 USD
CY2021Q1 nsp Treasury Stock Acquired
TreasuryStockAcquired
29686000 USD
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
17244000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15461000 USD
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
799000 USD
CY2021Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
2751000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43886000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-42396000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
9071000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-52502000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
807768000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
786699000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
816839000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
734197000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
575812000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
554846000 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
46929000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
45522000 USD
CY2021Q4 nsp Deposits Workers Compensation
DepositsWorkersCompensation
185027000 USD
CY2020Q4 nsp Deposits Workers Compensation
DepositsWorkersCompensation
186331000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
807768000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
786699000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
576654000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
494777000 USD
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
49429000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
46353000 USD
CY2022Q1 nsp Deposits Workers Compensation
DepositsWorkersCompensation
190756000 USD
CY2021Q1 nsp Deposits Workers Compensation
DepositsWorkersCompensation
193067000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
816839000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
734197000 USD
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
775000 USD
CY2022Q1 nsp Percentageofourhealthinsurancecoverageprovidedby United
PercentageofourhealthinsurancecoverageprovidedbyUnited
0.87
CY2019Q4 nsp Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence
WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence
1500000 USD
CY2022Q1 nsp Required Deposit For Health Care Costs
RequiredDepositForHealthCareCosts
6500000 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
12104000 USD
CY2022Q1 nsp Number Of Days In Advance Of Beginning Of Reporting Quarter Carrier Establishes Cash Funding Rates
NumberOfDaysInAdvanceOfBeginningOfReportingQuarterCarrierEstablishesCashFundingRates
P90D
CY2022Q1 nsp Prepaid Health Insurance Noncurrent
PrepaidHealthInsuranceNoncurrent
9000000 USD
CY2022Q1 nsp Prepaid Health Insurance Current And Noncurrent
PrepaidHealthInsuranceCurrentAndNoncurrent
13300000 USD
CY2022Q1 nsp Prepaid Health Insurance Noncurrent
PrepaidHealthInsuranceNoncurrent
9000000 USD
CY2022Q1 nsp Prepaid Health Insurance Current
PrepaidHealthInsuranceCurrent
4300000 USD
CY2022Q1 nsp Premiums Owed To United
PremiumsOwedToUnited
55000000 USD
CY2022Q1 nsp Benefits Costs Incurred Reduced Relatedto Runoff
BenefitsCostsIncurredReducedRelatedtoRunoff
800000 USD
CY2021Q1 nsp Benefits Costs Incurred Reduced Relatedto Runoff
BenefitsCostsIncurredReducedRelatedtoRunoff
5500000 USD
CY2022Q1 nsp Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence
WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence
1000000 USD
CY2022Q1 nsp Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence
WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence
1000000 USD
CY2022Q1 nsp Workers Compensation Maximum Aggregate Economic Burden For Claims In Excess Of First Layer Cap Per Policy Year
WorkersCompensationMaximumAggregateEconomicBurdenForClaimsInExcessOfFirstLayerCapPerPolicyYear
6000000 USD
CY2022Q1 nsp Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence
WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence
1000000 USD
CY2021Q1 nsp Us Treasury Rates That Correspond With Weighted Average Estimated Claim Payout Period
USTreasuryRatesThatCorrespondWithWeightedAverageEstimatedClaimPayoutPeriod
0.005
CY2022Q1 nsp Decrease Increase In Accrued Workers Compensation Costs For Changes In Estimated Losses
DecreaseIncreaseInAccruedWorkersCompensationCostsForChangesInEstimatedLosses
14900000 USD
CY2019Q4 nsp Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence
WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence
1500000 USD
CY2019Q4 nsp Workers Compensation Maximum Aggregate Economic Burden For Claims In Excess Of First Layer Cap Per Policy Year
WorkersCompensationMaximumAggregateEconomicBurdenForClaimsInExcessOfFirstLayerCapPerPolicyYear
6000000 USD
CY2019Q4 nsp Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence
WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence
1500000 USD
CY2021Q1 nsp Decrease Increase In Accrued Workers Compensation Costs For Changes In Estimated Losses
DecreaseIncreaseInAccruedWorkersCompensationCostsForChangesInEstimatedLosses
13200000 USD
CY2022Q1 nsp Us Treasury Rates That Correspond With Weighted Average Estimated Claim Payout Period
USTreasuryRatesThatCorrespondWithWeightedAverageEstimatedClaimPayoutPeriod
0.015
CY2021Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments
239623000 USD
CY2020Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments
240761000 USD
CY2022Q1 nsp Workers Compensation Expense
WorkersCompensationExpense
8373000 USD
CY2021Q1 nsp Workers Compensation Expense
WorkersCompensationExpense
9616000 USD
CY2022Q1 nsp Workers Compensation Discount Changed During Period
WorkersCompensationDiscountChangedDuringPeriod
-1309000 USD
CY2021Q1 nsp Workers Compensation Discount Changed During Period
WorkersCompensationDiscountChangedDuringPeriod
-442000 USD
CY2022Q1 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
14370000 USD
CY2021Q1 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
13246000 USD
CY2022Q1 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
232317000 USD
CY2021Q1 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
236689000 USD
CY2022Q1 nsp Workers Compensation Liability Net Of Admin Fees Current
WorkersCompensationLiabilityNetOfAdminFeesCurrent
49429000 USD
CY2021Q1 nsp Workers Compensation Liability Net Of Admin Fees Current
WorkersCompensationLiabilityNetOfAdminFeesCurrent
46353000 USD
CY2022Q1 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
182888000 USD
CY2021Q1 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
190336000 USD
CY2022Q1 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
232317000 USD
CY2021Q1 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
236689000 USD
CY2022Q1 nsp Workers Compensation Administrative Fees Accrued
WorkersCompensationAdministrativeFeesAccrued
3900000 USD
CY2022Q1 nsp Undiscounted Accrued Workers Compensation Costs
UndiscountedAccruedWorkersCompensationCosts
248000000 USD
CY2021Q1 nsp Undiscounted Accrued Workers Compensation Costs
UndiscountedAccruedWorkersCompensationCosts
253200000 USD
CY2022Q1 nsp Time Period Incurred Claims Expected To Be Paid Recorded As Restricted
TimePeriodIncurredClaimsExpectedToBePaidRecordedAsRestricted
P1Y
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
49400000 USD
CY2022Q1 nsp Deposits Workers Compensation
DepositsWorkersCompensation
190800000 USD
CY2022Q1 nsp Time Period Estimate Of Incurred Claim Costs To Be Paid Included In Short Term Liabilities
TimePeriodEstimateOfIncurredClaimCostsToBePaidIncludedInShortTermLiabilities
P1Y
CY2021Q4 nsp Unbilled
Unbilled
490500000 USD
CY2022Q1 nsp Unbilled
Unbilled
655300000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1577837000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1286835000 USD
CY2022Q1 nsp Money Market Funds Overnight Holdings At Carrying Value
MoneyMarketFundsOvernightHoldingsAtCarryingValue
566030000 USD
CY2021Q4 nsp Money Market Funds Overnight Holdings At Carrying Value
MoneyMarketFundsOvernightHoldingsAtCarryingValue
490154000 USD
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
45676000 USD
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
120742000 USD
CY2022Q1 us-gaap Cash
Cash
26736000 USD
CY2021Q4 us-gaap Cash
Cash
47331000 USD
CY2022Q1 srt Drafts Payable
DraftsPayable
29178000 USD
CY2021Q4 srt Drafts Payable
DraftsPayable
50624000 USD
CY2022Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
609264000 USD
CY2021Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
607603000 USD
CY2022Q1 nsp Payroll Withholdings Included In Cash Balance
PayrollWithholdingsIncludedInCashBalance
338300000 USD
CY2021Q4 nsp Payroll Withholdings Included In Cash Balance
PayrollWithholdingsIncludedInCashBalance
424800000 USD
CY2022Q1 nsp Client Prepayments Included In Cash Balance
ClientPrepaymentsIncludedInCashBalance
-117800000 USD
CY2021Q4 nsp Client Prepayments Included In Cash Balance
ClientPrepaymentsIncludedInCashBalance
-20100000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
579096000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
579105000 USD
CY2022Q1 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
6856000 USD
CY2021Q4 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
5782000 USD
CY2022Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
25754000 USD
CY2021Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
26009000 USD
CY2022Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
611706000 USD
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
610896000 USD
CY2022Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
500000000 USD
CY2022Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
550000000 USD
CY2022Q1 nsp Percentage Of Subsidiary Stock Securing Debt
PercentageOfSubsidiaryStockSecuringDebt
0.65
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
369400000 USD
CY2022Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1000000 USD
CY2022Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
129600000 USD
CY2022Q1 nsp Applicable Margin Federal Funds Rate
ApplicableMarginFederalFundsRate
0.0050
CY2022Q1 nsp Applicable Margin30 Day Libor
ApplicableMargin30DayLibor
0.0200
CY2022Q1 us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.0025
CY2022Q1 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.019
CY2022Q1 nsp Aggregatenumberofsharesrepurchasedduringtheperiod
Aggregatenumberofsharesrepurchasedduringtheperiod
308057 shares
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
209841 shares
CY2022Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
1493787 shares
CY2022Q1 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
98216 shares
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
17200000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15500000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
69884000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
61922000 USD
CY2022Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
47000 USD
CY2021Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
197000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
69837000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
61725000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38288000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38216000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
405000 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
623000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38693000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38839000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25000 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares

Files In Submission

Name View Source Status
0001000753-22-000022-index-headers.html Edgar Link pending
0001000753-22-000022-index.html Edgar Link pending
0001000753-22-000022.txt Edgar Link pending
0001000753-22-000022-xbrl.zip Edgar Link pending
a03312022-nspex311.htm Edgar Link pending
a03312022-nspex312.htm Edgar Link pending
a03312022-nspex321.htm Edgar Link pending
a03312022-nspex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nsp-20220331.htm Edgar Link pending
nsp-20220331.xsd Edgar Link pending
nsp-20220331_cal.xml Edgar Link unprocessable
nsp-20220331_def.xml Edgar Link unprocessable
nsp-20220331_g1.jpg Edgar Link pending
nsp-20220331_g10.jpg Edgar Link pending
nsp-20220331_g11.jpg Edgar Link pending
nsp-20220331_g2.jpg Edgar Link pending
nsp-20220331_g3.jpg Edgar Link pending
nsp-20220331_g4.jpg Edgar Link pending
nsp-20220331_g5.jpg Edgar Link pending
nsp-20220331_g6.jpg Edgar Link pending
nsp-20220331_g7.jpg Edgar Link pending
nsp-20220331_g8.jpg Edgar Link pending
nsp-20220331_g9.jpg Edgar Link pending
nsp-20220331_htm.xml Edgar Link completed
nsp-20220331_lab.xml Edgar Link unprocessable
nsp-20220331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending